experiments	Schema Version 3.36					
Please do not delete or edit this column						
Column Name	User Defined ID	Name	Description	Measurement Technique	Study ID	Protocol ID(s)
	12_101	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Spike"	ELISA	Reference_Study	RFF_Protocol
	12_102	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Spike,"	ELISA	Reference_Study	RFF_Protocol
	12_103	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	12_104	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	14_010	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Full Length Spike,"	ELISA	Reference_Study	RFF_Protocol
	14_020	chemiluminescent microparticle immunoassay (CMIA)	"SARS-CoV-2 Virus,Spike,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	14_050	chemiluminescent microparticle immunoassay (CMIA)	"Hepatitis B Virus,Core Antigen,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	14_070	chemiluminescent immunoassay (CLIA)	"Cytomegalovirus,CMV antigens,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	14_080	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Viral Capsid Antigen ,p18"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	14_090	enzyme-linked immunosorbent assay (ELISA)	"HCoV-229E,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	27_501	electrochemiluminescence immunoassay (ECLIA)	"SARS-CoV-2 Virus,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	27_502	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	27_503	enzyme-linked immunosorbent assay (ELISA)	"SARS-CoV-2 Virus,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	27_504	multiplex flow immunoassay	"Cytomegalovirus,CMV antigens,"	Multiplex Immunoassay	Reference_Study	RFF_Protocol
	27_505	multiplex flow immunoassay	"Epstein-Barr Virus,Viral Capsid Antigen ,"	Multiplex Immunoassay	Reference_Study	RFF_Protocol
	27_506	chemiluminescent microparticle immunoassay (CMIA)	"Hepatitis B Virus,Core Antigen,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	27_507	chemiluminescent microparticle immunoassay (CMIA)	"HIV,HIV 1 and HIV 2 antigens,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	27_508	lateral flow assay	"HIV,HIV 1 and HIV 2 antigens,"	Lateral Flow Assay	Reference_Study	RFF_Protocol
	27_509	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Viral Capsid Antigen ,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	27_510	chemiluminescent immunoassay (CLIA)	"Cytomegalovirus,CMV antigens,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	27_511	enzyme-linked immunosorbent assay (ELISA)	"HCoV-229E,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	32_035	chemiluminescent immunoassay (CLIA)	"Cytomegalovirus,CMV antigens,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	32_040	multiplex flow immunoassay	"Epstein-Barr Virus,Early Antigen Diffuse,"	Multiplex Immunoassay	Reference_Study	RFF_Protocol
	32_047	chemiluminescent immunoassay (CLIA)	"SARS-CoV-2 Virus,Spike,RBD"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	32_048	chemiluminescent immunoassay (CLIA)	"SARS-CoV-2 Virus,Spike,RBD"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	32_060	enzyme-linked immunosorbent assay (ELISA)	"HCoV-229E,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	32_065	enzyme-linked immunosorbent assay (ELISA)	"HCoV-HKU1,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	32_070	enzyme-linked immunosorbent assay (ELISA)	"HCoV-NL63,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	32_075	enzyme-linked immunosorbent assay (ELISA)	"HCoV-OC43,Nucleocapsid,"	ELISA	Reference_Study	RFF_Protocol
	41_468	chemiluminescent immunoassay (CLIA)	"Cytomegalovirus,CMV antigens,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_470	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Viral Capsid Antigen ,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_472	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Viral Capsid Antigen ,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_474	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Early Antigen Diffuse,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_476	chemiluminescent immunoassay (CLIA)	"Epstein-Barr Virus,Nuclear antigen - 1,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_481	chemiluminescent immunoassay (CLIA)	"SARS-CoV-2 Virus,Spike,S1/S2"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_483	chemiluminescent immunoassay (CLIA)	"SARS-CoV-2 Virus,Spike,SD"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_485	chemiluminescent microparticle immunoassay (CMIA)	"Hepatitis B Virus,Core Antigen,"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_486	enzyme-linked immunosorbent assay (ELISA)	"HCoV-229E,Spike,RBD"	ELISA	Reference_Study	RFF_Protocol
	41_487	electrochemiluminescence immunoassay (ECLIA)	"SARS-CoV-2 Virus,Nucleocapsid,Nucleocapsid (N) antigen"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
	41_488	electrochemiluminescence immunoassay (ECLIA)	"SARS-CoV-2 Virus,Spike,RBD"	Chemiluminescent Assay	Reference_Study	RFF_Protocol
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						
						